According to the Food and Drug Administration (FDA), Mylan is discontinuing Aerospan® (80 mcg). Aerospan is a corticosteroid inhaler used for daily asthma maintenance. Mylan notified the FDA on Jan. 26, 2018.
The medicine is being discontinued because of a business decision. The decision has nothing to do with the safety of the medicine or how well it works.
If you use Aerospan as part of your asthma treatment plan, contact your doctor right away so they can prescribe a new medicine for you.